Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ikaros Transcription Factor | 1 | 2024 | 232 | 0.840 |
Why?
|
Thalidomide | 1 | 2024 | 885 | 0.640 |
Why?
|
Central Nervous System Neoplasms | 2 | 2022 | 916 | 0.460 |
Why?
|
Antibodies, Antinuclear | 1 | 2015 | 343 | 0.450 |
Why?
|
Myelodysplastic Syndromes | 1 | 2018 | 1394 | 0.310 |
Why?
|
Liver Diseases | 1 | 2015 | 1298 | 0.270 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5146 | 0.270 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2016 | 2155 | 0.260 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.240 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.230 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2895 | 0.230 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 82 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4026 | 0.210 |
Why?
|
Immunotherapy | 1 | 2018 | 4652 | 0.210 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3613 | 0.210 |
Why?
|
Sirolimus | 3 | 2018 | 1533 | 0.190 |
Why?
|
Morpholines | 1 | 2024 | 581 | 0.190 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2811 | 0.180 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5821 | 0.160 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2022 | 646 | 0.150 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2016 | 38 | 0.140 |
Why?
|
Ethmoid Sinus | 1 | 2016 | 57 | 0.140 |
Why?
|
Isotope Labeling | 1 | 2018 | 392 | 0.140 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2016 | 71 | 0.140 |
Why?
|
Mitochondria, Liver | 1 | 2016 | 190 | 0.130 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8002 | 0.130 |
Why?
|
Caloric Restriction | 1 | 2018 | 299 | 0.130 |
Why?
|
Methotrexate | 1 | 2022 | 1719 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1897 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 844 | 0.120 |
Why?
|
Free Radical Scavengers | 1 | 2015 | 211 | 0.120 |
Why?
|
rab4 GTP-Binding Proteins | 1 | 2014 | 7 | 0.120 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 242 | 0.120 |
Why?
|
Acetylcysteine | 1 | 2015 | 260 | 0.110 |
Why?
|
Azathioprine | 1 | 2015 | 354 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2898 | 0.110 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 416 | 0.110 |
Why?
|
Ubiquitin | 1 | 2018 | 839 | 0.110 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 348 | 0.110 |
Why?
|
Cyclosporine | 1 | 2015 | 778 | 0.100 |
Why?
|
Phagosomes | 1 | 2014 | 199 | 0.100 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2016 | 339 | 0.100 |
Why?
|
Alanine Transaminase | 1 | 2015 | 603 | 0.100 |
Why?
|
Oxygen Consumption | 2 | 2016 | 1866 | 0.100 |
Why?
|
Complement System Proteins | 1 | 2015 | 736 | 0.100 |
Why?
|
Monoacylglycerol Lipases | 1 | 2012 | 36 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1405 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1896 | 0.090 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1051 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2018 | 2057 | 0.090 |
Why?
|
Phosphatidylinositols | 1 | 2012 | 282 | 0.090 |
Why?
|
Mitochondrial Membranes | 1 | 2012 | 176 | 0.090 |
Why?
|
Prednisone | 1 | 2015 | 1563 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1118 | 0.090 |
Why?
|
Sex Distribution | 1 | 2015 | 2281 | 0.090 |
Why?
|
Mitochondria | 2 | 2014 | 3624 | 0.080 |
Why?
|
Aspirin | 1 | 2021 | 3133 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2751 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2018 | 1469 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1076 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2021 | 5294 | 0.070 |
Why?
|
Muscle Proteins | 1 | 2012 | 1154 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4174 | 0.060 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 976 | 0.060 |
Why?
|
Autophagy | 1 | 2014 | 1326 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2016 | 3113 | 0.060 |
Why?
|
Anticoagulants | 1 | 2021 | 4812 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11121 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2455 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13639 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2865 | 0.050 |
Why?
|
Animals | 4 | 2024 | 168459 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2022 | 318 | 0.050 |
Why?
|
Humans | 11 | 2024 | 761504 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3617 | 0.040 |
Why?
|
Aging | 1 | 2018 | 8708 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8547 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14605 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15732 | 0.040 |
Why?
|
Microfluidics | 1 | 2023 | 653 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15842 | 0.040 |
Why?
|
Transaldolase | 1 | 2016 | 10 | 0.040 |
Why?
|
beta 2-Glycoprotein I | 1 | 2016 | 28 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 651 | 0.030 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2016 | 62 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5840 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5305 | 0.030 |
Why?
|
Leucine | 1 | 2018 | 548 | 0.030 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2016 | 153 | 0.030 |
Why?
|
Dynamins | 1 | 2016 | 139 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2022 | 64680 | 0.030 |
Why?
|
Blepharoptosis | 1 | 2016 | 144 | 0.030 |
Why?
|
Ocular Motility Disorders | 1 | 2016 | 144 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 80636 | 0.030 |
Why?
|
Male | 5 | 2022 | 360804 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 2014 | 389 | 0.030 |
Why?
|
Aged | 3 | 2022 | 169289 | 0.030 |
Why?
|
Macrolides | 1 | 2014 | 205 | 0.030 |
Why?
|
Cohort Studies | 1 | 2015 | 41487 | 0.030 |
Why?
|
Oculomotor Muscles | 1 | 2016 | 406 | 0.030 |
Why?
|
Phosphatidic Acids | 1 | 2012 | 49 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2018 | 1971 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6935 | 0.020 |
Why?
|
Antibody Formation | 1 | 2016 | 1395 | 0.020 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2012 | 201 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36426 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4544 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13446 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2192 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 2113 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17635 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1529 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3810 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5035 | 0.020 |
Why?
|
Middle Aged | 3 | 2022 | 220895 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22169 | 0.020 |
Why?
|
Adult | 3 | 2022 | 221177 | 0.020 |
Why?
|
Female | 5 | 2022 | 392644 | 0.020 |
Why?
|
Headache | 1 | 2016 | 1256 | 0.020 |
Why?
|
Proteome | 1 | 2018 | 1862 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1967 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1612 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 1989 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16981 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3792 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2022 | 58976 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2831 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22170 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3429 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21353 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9351 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14414 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8320 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81525 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15601 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4414 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18252 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 59243 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23445 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_